Table 2.

Comparison of patient characteristics with degree of self-management.

Characteristic	Total n=138	Fully independent n=79 (57%)	Partially independent n=37 (27%)	Delegator n=22 (16%)	P
Female	83 (60%)	49 (62%)	18 (49%)	16 (73%)	0.16
Crohn’s disease	73 (53%)	39 (49%)	22 (59%)	12 (55%)	0.59
Aminosalicylates only	41 (30%)	26 (33%)	10 (27%)	5 (23%)	0.60
Any immunomodulator	38 (28%)	20 (25%)	9 (24%)	9 (41%)	0.31
Any biologic	46 (33%)	23 (29%)	13 (35%)	10 (45%)	0.34
Pediatric onset (diagnosis at < 18y old)	31 (23%)	18 (23%)	11 (30%)	2 (10%)	0.21
Disease duration (years since diagnosis)	10.5 (6.0, 16.0)	11.0 (7.0, 16.0)	10.5 (6.0, 17.0)	5.0 (4.0, 16.0)	0.14

Degree of self-management excludes picking up medication from the pharmacy, and is undefined for 3 patients who failed to respond to one or more task questions.

Crohn’s patients were compared to colitis patients.

Patients on immunomodulators or biologics were compared to patients only on aminosalicylates or prescribed no drugs.

P-value from Pearson chi-square test or Kruskal-Wallis test. Age at diagnosis is unknown for 1 patient, and disease duration is unknown for 11 patients.